Recently, we had reported that PCI34051, an HDAC8 selective inhibitor, mitigates angiotensin II-induced hypertension and isoproterenol-induced cardiac hypertrophy [27, 28]. This evidence concerns the gene AGT and cardiac hypertrophy.